'Questions About Quitting' Smoking Cessation Trial (Q2)
|Smoking||Behavioral: Message Tone Behavioral: Navigation Behavioral: Proactive Outreach Behavioral: Testimonials|
|Study Design:||Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Single Blind (Participant)
Primary Purpose: Treatment
|Official Title:||Optimizing an Online Motivational Tobacco Cessation Program|
- Smoking Abstinence [ Time Frame: 12 months ]7 day point prevalent abstinence
- Treatment Utilization for Smoking Cessation [ Time Frame: 12 months ]confirmed use of pharmacotherapy or enrollment in health plan-sponsored counseling program
|Study Start Date:||May 2010|
|Study Completion Date:||November 2013|
|Primary Completion Date:||November 2012 (Final data collection date for primary outcome measure)|
Experimental: Message Tone
Prescriptive or Motivational
Persons are randomized to receive intervention content written in either a prescriptive or motivational tone.
Behavioral: Message Tone
All participants receive an tailored, online smoking cessation program. Participants in this intervention group either receive content written in a prescriptive tone or a motivational tone.
Persons are randomized to receive a personally tailored testimonial or not.
People receive a personally-tailored testimonial as part of their online smoking cessation program.
Dictated or Non-Dictated
Persons are randomly assigned to be able to freely navigate the website or to have their navigation of the website pre-determined based on their baseline readiness to quit smoking.
Persons in this arm either have their ability to navigate the site dictated for them based on their readiness to quit smoking or they are able to freely navigate through the website.
Experimental: Proactive Outreach
Email or No-Email communication
Persons are randomized to receive periodic email reminders to return to the intervention website or not.
Behavioral: Proactive Outreach
Persons receive periodic, proactively delivered email reminders to visit the intervention website.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00992264
|United States, Washington|
|Group Health Research Institute|
|Seattle, Washington, United States, 98101|
|Principal Investigator:||Jennifer B McClure, PhD||Group Health Research Institute|